| ||||||||||||||||||
|
BEIS
BIC bulletin
About us
|
Short Company profile
Sopharma JSC - Sofia
Branch: Manufacture of pharmaceutical preparations Licences & Certificates: Issuer
Large taxpayers and insurers
Member of GS1
Public company
Membership: Bulgarian Industrial Association General Meetings: Last - 27.06.2025
Registered Actitity: Medicines and pharmaceuticals production and trade; For the first ten months of the year, the turnover of the Bulgarian Stock Exchange (BSE) exceeded 1 billion leva, which is the highest level in the last 12 years, the exchange operator reported. Compared to the same period last year, when the turnover reached 706 million leva, the growth is 42 percent. The turnover of the Bulgarian Stock Exchange for the nine months was 859 million leva (439 million euros) and marked a growth of 29% on an annual basis. Four public companies Shelly Group (its shares are also traded in Frankfurt), Sopharma, Speedy and Chaikapharma High-Quality Medicines, already have a market capitalization of over 1 billion leva.
Bulgarian Stock Exchange JSC - Sofia Shelly Group SE- Sofia Sopharma JSC - Sofia Speedy JSC - Sofia Tchaikapharma High Quality Medicines to everyone in need of it JSC - Sofia
03.11.2025: Sopharma AD (SFA)
Sopharma AD sold 65,200 treasury shares... 03.11.2025: For the first ten months of the year, the turnover of the... 31.10.2025: Sopharma AD (SFA) Sopharma AD presented its quarterly report... 31.10.2025: Sopharma AD (SFA) Sopharma AD sold 5,300 treasury shares... 30.10.2025: Sopharma AD (SFA) Sopharma AD sold 5,500 treasury shares... 29.10.2025: Sopharma AD (SFA) Sopharma AD sold 3,350 treasury shares... 29.10.2025: Sopharma plans to raise 125 million leva with three warrant... 29.10.2025: Sopharma AD (SFA) Notification of a concluded preliminary... 28.10.2025: Sopharma AD (SFA) At its meeting, the Board of Directors of... 28.10.2025: Sopharma AD (SFA) Sopharma AD sold 295,445 treasury shares... This company profile is visited 24 738 times [2025: 3 135, 2024: 2 401, ... ] |
|
||||||||||||||||